磁共振与钼靶检查对乳腺导管原位癌的诊断价值

Diagnostic value of MRI and mammography in ductal carcinoma in situ of the breast

目的探讨MRI及钼靶对乳腺导管原位癌( ductal carcinoma in situ,DCIS)的诊断价值.方法选取2014年6月至2018年6月在长治医学院附属和济医院治疗的DCIS患者58例为研究对象,均行MRI以及钼靶检查,观察两种检查方法对其诊断效力.结果钼靶X线与MRI诊断吻合度:钼靶X线和MRI的吻合系数κ=0.452,表示两种诊断方式吻合度一般;不同检查方式诊断一致性对比:钼靶联合MRI应用诊断一致性(96.6%)明显高于钼靶X线(82.8%),差异有统计学意义(χ2 =5.95,P<0.05),与MRI(89.7%)差异无统计学意义(χ2 =2.43,P>0.05).结论钼靶和MRI在诊断乳腺导管原位癌有各自特点,联合应用能够提高诊断效果.

Objective To investigate the diagnostic value of MRI and molybdenum target in ductal carcinoma in situ (DCIS).Methods From June 2014 to June 2018,58 patients diagnosed as DCIS in Heji Hospital Affiliated to Changzhi Medical College were chosen.MRI and mammography were performed,and the diagnostic potency of the two methods was observed.Results The coincidence degree of molybdenum target X-ray and MRI diagnosis:the coincidence coefficient kappa=0.452 of molybdenum target X ray and MRI showed that the two diagnostic methods were in general anastomosis.The diagnostic consistency of different examination methods:the diagnostic consistency of molybdenum target combined with MRI ( 96. 6%) was significantly higher than that of molybdenum target X (82.8%),the difference was statistically significant (χ2 =5.95,P<0.05),and there was no statistically significant difference compared with MRI (89.7%) ( χ2 =2.43, P >0.05). Conclusion Molybdenum target and MRI in diagnosis of DCIS have their own characteristics.Combined application can improve the diagnostic effect.